pr5b00709_si_002.pdf (92.13 kB)
Download file

N‑Glycosylation of Serum IgG and Total Glycoproteins in MAN1B1 Deficiency

Download (92.13 kB)
journal contribution
posted on 02.10.2015, 00:00 authored by Radka Saldova, Henning Stöckmann, Roisin O’Flaherty, Dirk J. Lefeber, Jaak Jaeken, Pauline M. Rudd
MAN1B1-CDG has recently been characterized as a type II congenital disorder of glycosylation (CDG), disrupting not only protein N-glycosylation but also general Golgi morphology. Using our high-throughput, quantitative ultra-performance liquid chromatography assay, we achieved a detailed characterization of the glycosylation changes in both total serum glycoproteins and isolated serum IgG from ten previously reported MAN1B1-CDG patients. We have identified and quantified novel hybrid high-mannosylated MAN1B1-CDG-specific IgG glycans and found an increase of sialyl Lewis x (sLex) glycans on serum proteins of all patients. This increase in sLex has not been previously reported in any CDG. These findings may provide insight into the pathophysiology of this CDG.

History